Literature DB >> 2325116

The incidence of anaerobes in the sputum of patients with cystic fibrosis.

L A Jewes1, R C Spencer.   

Abstract

The number of anaerobes in selected sputum samples from patients with cystic fibrosis (CF) was investigated. When cultured by a semi-quantitative method, 26 (23.85%) of 109 sputum specimens from 21 CF patients contained greater than 10(5) cfu of anaerobic organisms/ml. Nine (42.7%) of the 21 patients produced sputum containing such concentrations of anaerobes on at least one occasion. Anaerobes were isolated from repeated sputum specimens from five patients. The anaerobes most often isolated were Bacteroides disiens, pigmented Bacteroides spp. and anaerobic gram-positive cocci. Anaerobes were isolated more often from sputum liquefied by sonication than from unliquefied sputum, suggesting that they were unlikely to be oropharyngeal contaminants.

Entities:  

Mesh:

Year:  1990        PMID: 2325116     DOI: 10.1099/00222615-31-4-271

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  10 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 2.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

3.  A Novel Depsipeptide Produced by Paenibacillus alvei 32 Isolated from a Cystic fibrosis Patient.

Authors:  Romain Chevrot; Sandrine Didelot; Larissa Van den Bossche; Fatoumata Tambadou; Thibault Caradec; Pierre Marchand; Esther Izquierdo; Valérie Sopéna; Jocelyne Caillon; Cyrille Barthélémy; Ann Van Schepdael; Jos Hoogmartens; Eric Rosenfeld
Journal:  Probiotics Antimicrob Proteins       Date:  2013-03       Impact factor: 4.609

4.  Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum.

Authors:  Kelli L Palmer; Stacie A Brown; Marvin Whiteley
Journal:  J Bacteriol       Date:  2007-03-30       Impact factor: 3.490

5.  Oxygen levels rapidly modulate Pseudomonas aeruginosa social behaviours via substrate limitation of PqsH.

Authors:  Jeffrey W Schertzer; Stacie A Brown; Marvin Whiteley
Journal:  Mol Microbiol       Date:  2010-08-17       Impact factor: 3.501

Review 6.  Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi.

Authors:  James F Chmiel; Timothy R Aksamit; Sanjay H Chotirmall; Elliott C Dasenbrook; J Stuart Elborn; John J LiPuma; Sarath C Ranganathan; Valerie J Waters; Felix A Ratjen
Journal:  Ann Am Thorac Soc       Date:  2014-10

Review 7.  New antimicrobial strategies in cystic fibrosis.

Authors:  Mireille van Westreenen; Harm A W M Tiddens
Journal:  Paediatr Drugs       Date:  2010-12-01       Impact factor: 3.022

8.  Diagnosis of bronchopulmonary infections by quantification of microflora.

Authors:  F Pirali; M Longo; M Gelmi; D Colombrita; G Ravizzola; G Pinsi; L Peroni; N Manca; A Turano
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

9.  Bacterial activity in cystic fibrosis lung infections.

Authors:  Geraint B Rogers; Mary P Carroll; David J Serisier; Peter M Hockey; Valia Kehagia; Graeme R Jones; Kenneth D Bruce
Journal:  Respir Res       Date:  2005-06-01

10.  Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients.

Authors:  Fadi Bittar; Hervé Richet; Jean-Christophe Dubus; Martine Reynaud-Gaubert; Nathalie Stremler; Jacques Sarles; Didier Raoult; Jean-Marc Rolain
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.